Gene Query: EHHADH

Dataset Description Geneva Score
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 28.85
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 27.78
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 24.44
RNA sequencing of matched nephrectomy samples [RNA-seq] 24.43
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 24.43
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 22.66
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 22.32
Androgen Receptor-regulated genes in prostate cancer cells 19.51
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 19.51
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 19.04
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 19.04
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 18.57
Genome-wide identification of cancer-specific alternative splicing in circRNA 17.4
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 15.89
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 15.15
Gene expression analysis of human liver progenitor-like cells in culture 14.65
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 13.44
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 13.29
Gene expression analysis of immortalized human liver progenitor-like cells in culture 12.9
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 12.47
The expression profiles of GBC liver metastasis 11.52
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.43
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 11.18
Role of CD133 molecule in WNT response and renal repair 10.64
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 10.38
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 10.27
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 9.78
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 9.28
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 9.28
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 9.17
Gene expression profile difference among renal location in a stone former 8.52
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.38
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.38
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 8.35
Mechanistic Model-Guided Study of Embryonic Morphogenesis 8.23
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 8.18
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.49
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.24
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 7.2
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 7.2
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.04
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.91
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.75
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 6.74
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 6.63
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 6.43
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 6.37
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 6.37
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 6.35
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 6.35
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 6.29
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 6.22
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 5.96
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.95
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.77
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.77
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 5.74
Gene expression patterns define the hepatocyte-like cells derived by different strategies 5.56
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 5.56
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.21
SRSF2 mutations impair hematopoiesis and alter exon recognition 5.12
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.08
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 5.03
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.03
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.94
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.77
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 4.77
Single-nucleotide-resolution mapping of HBV promoters using CAGE 4.71
Cellular response to hepatitis E virus (HEV) infection 4.69
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 4.51
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 4.47
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 4.47
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 4.37
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 4.37
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.37
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.22
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.19
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 4.11
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.02
Differentially expressed genes post knock down of lincDUSP26 3.86
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.81
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.81
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 3.8
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.8
Evolution of a transcriptional regulator from a transmembrane nucleoporin 3.73
RNA-seq in HepG2 and IMR90 cells 3.73
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.62
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 3.61
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.56
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.55
Hepatitis C virus functionally sequesters miR-122 3.55
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.48
Hepatic transcriptome of pediatric hepatoblastoma. 3.44
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.4
Knockdown of ADNP in HCT116 colon cancer cells 3.4
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.37
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.32
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 3.28
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.19
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.19
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.11
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.09
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.03
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 3.01
Repurposing of promoters and enhancers during mammalian evolution 2.94
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.88
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 2.81
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.81
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.76
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 2.76
RNA-seq analysis of uveal melanoma cells treated with FR900359 2.76
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.72
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 2.69
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.67
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.66
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 2.66
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 2.65
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 2.63
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.62
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.62
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.61
Gene expression of collecting duct carcinoma of the kidney 2.61
Gene expression changes associated with resistance to tagraxofusp (SL-401) 2.55
Total RNA sequencing of APC mutant and wt colonic organoids 2.54
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 2.53
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 2.52
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 2.52
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.52
Universal alternative splicing of noncoding exons 2.5
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 2.5
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.47
An RNA-centric dissection of host complexes controlling flavivirus infection 2.47
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 2.47
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.44
Identification of a LIF-responsive replication-competent human β cell 2.43
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 2.36
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.33
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.33
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 2.31
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 2.31
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 2.3
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.28
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.28
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 2.26
Gene expression analysis of dengue-infected cells 2.24
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.19
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.18
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 2.17
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.16
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 2.15
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 2.15
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.14
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.13
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.13
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.09
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 2.07
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 2.07
Identification of expressed and conserved human non-coding RNAs 2.07
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.07
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.07
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 2.05
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.04
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.04
STX4 Over-Expression in Human islets 2.03
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.03
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.98
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.97
Total RNA sequencing of WT intestinal orgaonids. 1.94
Crizotinib v. DMSO in SW480 cells 1.94
LNCaP treated with iBET 1.92
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 1.91
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 1.87
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.86
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.83
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.82
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.82
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 1.82
HNF1 regulates critical functions of the human epididymis epithelium. 1.82
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.79
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 1.78
HEK293 TFAM Knockout Expression Study 1.77
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 1.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 1.75
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.75
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.75
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.74
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.73
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.7
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.7
SLIGRL-induced gene expression changes in NHEK cells 1.68
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.68
HNRNPL and its RNA Targets in Prostate Cancer 1.68
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 1.68
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.68
Genome-wide chromatin analysis of Ewing sarcoma 1.68
RNA-sequencing 1.67
RNA-sequencing of human liver tissue 1.65
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 1.64
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.63
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.63
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.61
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.61
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.59
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.58
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.57
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.57
Gene expression changes caused by KRAS in MCF-10A 1.55
The effect of PPARG inhibition on human angiomyolipoma cells 1.54
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 1.54
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.54
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 1.54
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.53
Functional role of SLIT2 and ROBO1 in trophoblasts 1.53
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.52
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 1.52
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.51
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 1.49
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.49
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.45
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 1.44
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.44
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.43
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 1.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.41
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.41
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.41
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.41
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 1.4
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.38
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.38
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.38
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.38
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.33
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.33
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.33
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 1.26
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 1.26
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.25
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.25
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 1.24
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 1.24
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 1.24
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.22
Transcriptome analyses of human pancreatic islets and pseudoislets 1.22
RNAseq Study in CC-671 Treated Cal-51 Cells 1.22
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.22
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.21
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.2
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.2
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.19
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.17
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.17
Postnatal lipids drive hepatocyte maturation 1.16
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 1.16
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.15
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 1.14
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.14
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.14
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.13
Genome-wide functional assessment of enhancer activities in the human genome 1.13
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 1.13
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 1.13
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.13
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.12
Gene profiling of human adult and pediatric liver cancer cells 1.12
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 1.1
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.09
Identification of long noncoding RNAs regulated by p53 1.09
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.09
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.09
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.08
Global analyses of the effect of different cellular contexts on microRNA targeting 1.08
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 1.08
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.07
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.07
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.07
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 1.06
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 1.06
Ebola virus (EBOV) infection of ARPE-19 cells 1.05
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.04
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 1.04
T47D RNA-seq and ChrRNA-seq data 1.04
Identifying the molecular mode of action of itraconazole in colorectal cancer 1.03
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 1.03
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.03
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 1.02
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.02
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.01
RNA-seq analysis of AML cells in response to ASLAN003 0.99
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 0.98
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 0.96
mRNA sequencing of oropharyngeal cancer cell lines 0.94
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.93
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.92
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.92
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.92
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.92
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.92
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.91
The transcriptome and chromatin accessbility landscape of mammalian germline 0.9
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 0.9
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.9
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.9
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.89
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.88
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.88
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 0.88
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.88
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.87
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.85
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.83
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.81
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.81
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.81
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 0.8
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.79
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 0.78
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.78
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.77
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 0.75
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.75
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.75
The role of the Calcium-Sensing receptor in colorectal cancer 0.75
Transcriptome of human white and brown adipose tissue biopsies 0.74
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.71
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.71
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 0.69
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.69
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.68
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.68
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.68
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.68
Transcriptional responses of melanoma cells to BRAF inhibition 0.67
The MEF2B Regulatory Network - RNA-seq data 0.67
The MEF2B Regulatory Network 0.67
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.65
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 0.65
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.65
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.64
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 0.64
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.64
Integrin signaling regulates YAP/TAZ to control skin homeostasis 0.64
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.63
Gene expression analysis of human hepatocellular cancers 0.62
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 0.62
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.62
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.61
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.61
Iron response of HepG2 cells 0.61
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.61
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 0.6
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.59
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.59
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.59
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.57
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.57
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.57
Transcriptomic profile of human embryonic renal corpuscles 0.57
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.56
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.56
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.56
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.55
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.55
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.55
Evaluating pre-clinical models for studying NASH driven HCC. 0.55
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.54
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 0.54
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.53
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.52
Gene expression analysis of human adenomas. 0.52
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.51
JAK dependent survival of ALK- ALCL 0.51
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.5
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.5
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.5
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.49
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.49
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.48
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 0.48
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.47
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.47
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.47
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.47
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 0.46
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.46
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.44
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.43
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.43
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.41
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.41
iPSC-Derived Cholangiocytes 0.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.4
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.4
Molecular analysis of renal cell carcinoma with unclassfied histology 0.4
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.39
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.39
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.39
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.38
Transcriptional landscape changes during human embryonic stem cell derivation 0.38
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.37
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.36
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.36
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.36
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.35
Transcriptome of EBV-infected gastric cancer cell lines 0.34
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.34
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.33
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.33
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.32
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.32
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.29
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.29
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.29
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.28
Dilated cardiomyopathy vs Myocarditis 0.28
The gene expression profiles of gallbladder cancer 0.27
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.27
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.27
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.26
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 0.26
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.25
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.25
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.24
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.24
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.24
Common inflammatory pathways between NEC and Crohn's disease 0.24
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.24
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.23
RNA-Seq of the corpus callosum from 12 individuals 0.23
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.23
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.23
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.22
Expression profiling of converted and control dermal BJ fibroblasts 0.22
RNAseq analysis of ruxolitinib treated breast cancers 0.22
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.21
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.21
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.2
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.19
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 0.19
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.19
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 0.18
RNA-seq of SCLC PDX models treated with EP 0.18
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.17
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.17
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.17
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.17
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.16
Effect of nuclear IL-33 on gene expression 0.16
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.14
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.14
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.14
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.14
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.14
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.12
Hepatocyte maturation 0.12
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.12
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.11
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.11
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.11
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.1
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.09
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.09
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.09
RNA-seq data 0.09
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.09
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.09
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.09
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.08
KSDM1b Role in Ewing Sarcoma 0.08
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.08
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.07
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.07
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.06
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.06
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.06
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.06
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.06
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.06
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.06
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.06
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.05
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.05
MicroRNA-125a-5p overexpression in human macrophages 0.05
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.05
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.05
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.05
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.05
RNA-Seq and expression data from human adipose tissue 0.05
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.04
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.03
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.03
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.03
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.03
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.03
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation